Rare lobular capillary hemangioma associated with azacitidine in high‐risk myelodysplastic syndrome patient
- 16 February 2021
- journal article
- letter
- Published by Hindawi Limited in Dermatologic Therapy
- Vol. 34 (2), e14884
- https://doi.org/10.1111/dth.14884
Abstract
Click on the article title to read more.Keywords
This publication has 7 references indexed in Scilit:
- The Epigenetic Profile of Tumor Endothelial Cells. Effects of Combined Therapy with Antiangiogenic and Epigenetic Drugs on Cancer ProgressionInternational Journal of Molecular Sciences, 2020
- Cutaneous adverse events induced by azacitidine in myelodysplastic syndrome patients: Case reports and a lesson from published work reviewThe Journal of Dermatology, 2020
- Dynamic Interplay between Pericytes and Endothelial Cells during Sprouting AngiogenesisCells, 2019
- Azacitidine-associated pleuropericardial effusion in myelodysplastic syndrome: A case reportJournal of Oncology Pharmacy Practice, 2018
- Role of tumour angiogenesis in haematological malignanciesSwiss Medical Weekly, 2014
- Endothelial cells of oral pyogenic granulomas express eNOS and CD105/endoglin: an immunohistochemical studyJournal of Oral Pathology & Medicine, 2010
- Lobular capillary hemangiomas: An epidemiologic report, with emphasis on cutaneous lesionsJournal of the American Academy of Dermatology, 2000